Biography

I obtained my PhD in the Bone Oncology group of Prof. Ingunn Holen and Prof. Penelope Ottewell in the Department of Oncology & Metabolism at The University of Sheffield Medical School, which was awarded in October 2017. My PhD project focussed on developing novel models of mitotic quiescence in human breast cancer cells in vitro and metastatic dormancy in vivo. My early postdoctoral work was focussed on characterising the cellular sub-populations isolated from these models using a multitude of approaches, including next-generation sequencing.

In early 2019, I undertook a three-month training placement in high-performance computing (HPC) and bioinformatic analysis of RNA sequencing (RNA-Seq) data at the Kinghorn Centre for Clinical Genomics at the Garvan Institute of Medical Research in Sydney, Australia working under Dr Nenad Bartonicek.

Beginning in September 2019, I transitioned to a two-year position as a postdoctoral cancer bioinformatician and in June 2022 moved to a full-time role as cancer bioinformatician embedded within the Sheffield Bioinformatics Core Facility working in the group of Prof. James Catto on several clinical projects involving large-scale next-generation sequencing and clinical data analysis.

In May 2023 I was appointed as a Senior Lecturer in Data Science and Analytics in the Department of Computing at Sheffield Hallam University and awarded a three-year honorary post as Senior Lecturer in Bioinformatics in the Department of Oncology and Metabolism at the University of Sheffield.

My current research activity is centred on numerous cancer types, including projects aiming to create a mutational map of the 100,000 Genomes Project bladder cancer and ovarian cancer cohorts, a project aiming to develop a model to predict response to therapy in gestational trophoblastic disease, and a project aiming to identify molecular drivers of metastatic dormancy in breast cancer. I am also contributing bioinformatics capability to the Genotype of Urothelial Cancer - Stratified Treatment and Oncological outcomes (GUSTO) phase II clinical study, as well as supporting several smaller clinical, basic science and student-led projects in a diverse range of areas including public healthcare data, text mining and sentiment analysis, and predictive modelling.

Publications

This section contains an up-to-date list of publications that I have authored.

Original Manuscripts

Griffin, J., Down, J., Quayle, L.A., Heath, P., Gibb, E.A., Davicioni, E., Liu, Y., Zhao, X., Swain, J., Wang, D., Hussain, S., Crabb, S., Catto, JWF. on behalf of the GUSTO Trial Management Group (2024) Verification of Molecular Subtyping of Bladder Cancer in the GUSTO Clinical Trial. J Pathol Clin Res, 1;10(2):e12363.

Catto, J.W.F., Mandrik, O., Quayle, L.A., Hussain, S.A., McGrath, J., Cresswell, J., Birtle, A.J., Jones, R.J., Mariappan, P., Makaroff, L.E., Knight, A., Mostafid, H., Chilcott, J., Sasieni, P., Cumberbatch M. (2023). Diagnosis, treatment and survival from bladder, upper urinary tract and urethral cancers: Real world findings from NHS England between 2013 and 2019. BJU Int, 131(6): 734-744.

Quayle, L.A., Spicer, A., Ottewell, P.D., Holen, I. (2021). Transcriptomic Profiling Reveals Novel Candidate Genes and Signalling Programs in Breast Cancer Quiescence and Dormancy. Cancers, 13(16): 3922.

Tulotta, C., Lefley, D., Moore, C., Amariutei, A., Spicer, A., Quayle, L., Hughes, R., Ahmed, K., Cookson, V., Evans, C., Vadakekolathu, J., Heath, P., Francis, F., Pinteaux, E., Pockley, A., Ottewell, P.D. (2021). IL-1B drives opposing responses in primary tumours and bone metastases; harnessing combination therapies to improve outcome in breast cancer. NPJ Breast Cancer, 7(1): 95.

Quayle, L.A., Ottewell, P.D., Holen, I. (2018). Chemotherapy Resistance and Stemness in Mitotically Quiescent Human Breast Cancer Cells Identified by Fluorescent Dye Retention. Clin Exp Metastasis, 35(8): 831-846.

Quayle, L.A., Pereira, M.G., Scheper, G., Wiltshire, T., Peake, R.E., Hussain, I., Rea, C.A. & Bates, T.E. (2017). Anti-angiogenic drugs: direct anti-cancer agents with mitochondrial mechanisms of action. Oncotarget, 8 (51): 88670-88688.

Quayle, L., Ottewell, P.D., Holen, I. (2015). Bone Metastasis: Molecular Mechanisms Implicated in Tumour Cell Dormancy in Breast and Prostate Cancer. Curr Cancer Drug Targets. 15: 469-480.

Book Chapters

Holen, I. and Quayle, L.A. (2020). Stem cell niches in bone and their roles in cancer metastasis. Advances in Stem Cells and their Niches. Elsevier. 5: 35-62.

Ottewell, P.D. and Quayle, L.A. (2019) Tumor Dormancy in the Bone. Encyclopaedia of Bone Biology. Elsevier. 166 - 179.

Conference Proceedings

Griffin, J., Down, J., Quayle, L., Heath, P., Catto, J. (2023) Pathology Against the Clock: Verification of Gene Expression Subtyping for the GUSTO Clinical Trial. Liverpool Pathology 2023. 14th Joint Meeting of the BDIAP and The Pathological Society, 27-29 June 2023. J Pathol. 261 Suppl 1:S3-S69: Abstract P85.

Quayle, L., Ottewell, P.D., Holen, I. (2018) Therapeutic Resistance and Stemness in Mitotically Quiescent Human Breast Cancer Cells. 1st UK Interdisciplinary Breast Cancer Symposium 15th – 16th January 2018; Manchester, U.K. Breast Cancer Res Treat. 167:309–405: Abstract P10.12.

Quayle, L., Park, S., McDonnell, D.P., Ottewell, P.D., Holen, I. (2017) Targeting ERR-α Regulated Lactate Metabolism Eliminates Drug-Resistant Breast Cancer Cells. Proceedings of the 2016 San Antonio Breast Cancer Symposium 6th – 10th December 2016; San Antonio, TX, U.S.A. Cancer Res. 77(4 Suppl): Abstract P3-07-14.

Peer Review

Acta Pharmaceutica Sinica B
Cancer Chemotherapy and Pharmacology
Clinical & Experimental Metastasis
Journal of Cellular Biochemistry
Journal of Tissue Engineering and Regenerative Medicine

Editorial Board Membership

Clinical & Experimental Metastasis (2023 - Present)

Professional Memberships

British Association for Cancer Research (2014 - Present)
European Association for Cancer Research (2014 - Present)
Institute of Biomedical Science (2011 - 2017)
Royal Society of Biology (2011 - 2017)

Teaching Qualifications

I have been awarded the Advance HE Fellowship. This award demonstrates a personal and institutional commitment to professionalism in learning and teaching in higher education, and that my higher education (HE) teaching and/or support for learning practice meets all 15 points of the Professional Standards Framework 2023.

I have also reached certified The Carpentries Instructor status. This certification demonstrates my understanding of core evidence-based teaching practices and pedagogical concepts that qualify me to teach foundational coding and data science skills to researchers under the core curriculum of Data Carpentry, Library Carpentry, and Software Carpentry.

Skills Summary

Below is a brief overview of some of my analytical skills and competencies:

Programming in R, SQL, and Unix (BASh)
Auxiliary tools such as Markdown, Git, Conda and Nextflow
Containerisation technologies Singularity (Apptainer) and Docker
Pipeline development and deployment on high-performance computing (HPC) or cloud-based infrastructure
Microarray, RNA-Seq (bulk and single-cell), Whole Genome (WGS) and Whole Exome (WES) sequencing data analysis
Relational database access and analysis
Large-scale clinical data cleaning and integration
Time-to-event (survival) analysis
Interaction network construction, validation, and analysis
Geospatial data analysis
Text mining
Unsupervised and supervised machine learning model development and deployment
Advanced data visualisation
Self-service interactive dashboard and web app development

Programming Qualifications

This section contains an up-to-date list of links (in alphabetical order) to certificates gained through my commitment to continuous professional development (CPD).